Halting further spread of multidrug-resistant tuberculosis (MDR-TB) require
s both new resources and a renewed discussion of priority setting informed
by estimates of the existing burden of this disease. The 1997 report of the
first phase of the global survey by the World Health Organization (WHO) an
d the International Union Against Tuberculosis and Lung Disease (IUATLD) us
es the indicator of the proportion of TB cases that are MDR-TB to identify
MDR-TB 'hot spots'. We sought to refine the definition of MDR-TB transmissi
on 'hot spots'. For this purpose, we obtained estimates of two additional i
ndicators for regions where data are available: MDR-TB incidence per 100 00
0 population per year, and expected numbers of new patients with MDR-TB per
year. There is generally much agreement in the three indicators considered
, and some differences also appear. We conclude that it is useful, when def
ining indicators of MDR-TB transmission 'hot spots', to include estimates o
f underlying TB incidence rates and of absolute numbers of MDR-TB cases. Es
timating the force of morbidity of MDR-TB in a population is important for
comparing this burden across settings with very different underlying TB inc
idence rates; estimating the absolute number of MDR-TB patients will be cri
tical for planning the delivery of directly observed MDR-TB therapy and the
rational procurement of second-line drugs. Through this exercise, we aim t
o initiate discussion about improved methods of quantifying and comparing c
urrent MDR-TB transmission 'hot spots' that require intervention.